These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11015694)

  • 1. Physicochemical and crystallographic evidence for polymorphism of the racemic ethyl (2-chloromethyl-2,3-dihydro-5H-oxazolo [3, 2-a]pyrimidin-5-one)-6-carboxylate.
    Chaimbault C; Bosc JJ; Leger JM; Negrier P; Capelle F; Jarry C
    J Pharm Sci; 2000 Nov; 89(11):1496-504. PubMed ID: 11015694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray structural studies and physicochemical characterization of (E)-6-(3,4-dimethoxyphenyl)-1-ethyl-4-mesitylimino-3-methyl- 3,4-dihydro-2(1H)-pyrimidinone polymorphs.
    Miyamae A; Kitamura S; Tada T; Koda S; Yasuda T
    J Pharm Sci; 1991 Oct; 80(10):995-1000. PubMed ID: 1784011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of solid-state nature of 2-chloromandelic acid.
    He Q; Zhu J; Gomaa H; Jennings M; Rohani S
    J Pharm Sci; 2009 May; 98(5):1835-44. PubMed ID: 18837015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First 3-D structure determination of a peptide oxazol-5(4H)-one with a chiral protein amino acid in the heterocyclic moiety: an x-ray diffraction analysis of the enantiomeric and racemic Goodman oxazolone.
    Crisma M; Valle G; Moretto V; Formaggio F; Toniolo C
    Pept Res; 1995; 8(3):187-90. PubMed ID: 7670234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid tryptophan as a pseudoracemate: physicochemical and crystallographic characterization.
    Li Y; Zhao Y; Zhang Y
    Chirality; 2015 Jan; 27(1):88-94. PubMed ID: 25354341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of Alprazolam (Xanax): a review of its crystalline phases and identification, crystallographic characterization, and crystal structure of a new polymorph (form III).
    de Armas HN; Peeters OM; Van den Mooter G; Blaton N
    J Pharm Sci; 2007 May; 96(5):1114-30. PubMed ID: 17455340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of tedisamil dihydrochloride.
    Henck JO; Finner E; Burger A
    J Pharm Sci; 2000 Sep; 89(9):1151-9. PubMed ID: 10944380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crystalline polymorphism of eflucimibe].
    Ribet JP; Pena R; Chauvet A; Patoiseau JF; Autin JM; Segonds R; Basquin M; Autret JM
    Ann Pharm Fr; 2002 May; 60(3):177-86. PubMed ID: 12050596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen bonding due to regioisomerism and its effect on the supramolecular architecture of diethyl 2-[(2/4-hydroxyanilino)methylidene]malonates.
    Ilangovan A; Venkatesan P; Ganesh Kumar R
    Acta Crystallogr C; 2013 Jan; 69(Pt 1):70-3. PubMed ID: 23282918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
    Huang J; Chen S; Guzei IA; Yu L
    J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physicochemical properties of suplatast tosilate racemate and enantiomers].
    Ushio T; Endo K; Yamamoto K
    Yakugaku Zasshi; 1996 Nov; 116(11):866-75. PubMed ID: 8981830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M
    J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical, crystallographic, thermal, and spectroscopic behavior of crystalline and X-ray amorphous ciclesonide.
    Feth MP; Volz J; Hess U; Sturm E; Hummel RP
    J Pharm Sci; 2008 Sep; 97(9):3765-80. PubMed ID: 17975810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of 1,2-dihydro-6-neopentyl-2-oxonicotinic acid: characterization, interconversion, and quantitation.
    Chao RS; Vail KC
    Pharm Res; 1987 Oct; 4(5):429-32. PubMed ID: 3508554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Para-derivatized pybox ligands as sensitizers in highly luminescent Ln(III) complexes.
    de Bettencourt-Dias A; Barber PS; Viswanathan S; de Lill DT; Rollett A; Ling G; Altun S
    Inorg Chem; 2010 Oct; 49(19):8848-61. PubMed ID: 20809608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in metoclopramide hydrochloride and metoclopramide.
    Mitchell AG
    J Pharm Pharmacol; 1985 Sep; 37(9):601-4. PubMed ID: 2867177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential enrichment: full crystallographic analysis of the unusual phenomenon in the mixed crystals' version.
    Takahashi H; Tamura R; Fujimoto D; Lepp Z; Kobayashi K; Ushio T
    Chirality; 2002 Jul; 14(7):541-7. PubMed ID: 12112325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization of deflazacort: thermal analysis, crystallographic and spectroscopic study.
    Cuffini SL; Ellena JF; Mascarenhas YP; Ayala AP; Sielser HW; Filho JM; Monti GA; Aiassa V; Sperandeo NR
    Steroids; 2007 Mar; 72(3):261-9. PubMed ID: 17207826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of polymorphic ampicillin forms.
    Baraldi C; Tinti A; Ottani S; Gamberini MC
    J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.